Tag: chemistry
-
Biotech to Design Disease-Blocking Drugs, Gains $75M
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round.
-
Light-Activated Therapy Improves Vision in Inherited Disease Trial
A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder.
-
Biotech Partners on Synthetic Proteins to Protect Crops
A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls.
-
Biotech Gains $53.7M Infectious Disease Test Award
A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections.
-
Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-
Biotech, Undersea Researchers Partner on Carbon Capture Bacteria
A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide.
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
Seaweed Biomaterials Start-Up Gains $5M in Early Funds
A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round.
-
Investor Backing Nanotech Drug Discovery Advances
A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands.
-
Biotechs Partner to Boost mRNA Manufacturing
Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing.